Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1- piperazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4-iodophenyl)-2- aminopropane HCl (DOI)

Q. Li, M. S. Brownfield, G. Battaglia, T. M. Cabrera, A. D. Levy, P. A. Rittenhouse, L. D. Van de Kar

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1- piperazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4-iodophenyl)-2- aminopropane HCl (DOI)'. Together they form a unique fingerprint.

Medicine & Life Sciences